{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:51Z","timestamp":1707524751892},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,22]]},"DOI":"10.7759\/cureus.29444","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:48:45Z","timestamp":1663850925000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Hepatic Steatosis With Coronary Artery Disease by Studying the Role of Individual and Demographic Risk Factors"],"prefix":"10.7759","author":[{"given":"Omar","family":"Alserihy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Alsallumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar S","family":"Al-Sulami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-12930","article-title":"Imaging of hepatic steatosis","volume":"21","author":"Siegelman ES","year":"2001","unstructured":"Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis. 2001, 21:71-80. 10.1055\/s-2001-12930","journal-title":"Semin Liver Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo P","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346:1221-31. 10.1056\/NEJMra011775","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1198","article-title":"Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do","volume":"27","author":"Lebovics E","year":"2011","unstructured":"Lebovics E, Rubin J. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do. Diabetes Metab Res Rev. 2011, 27:419-24. 10.1002\/dmrr.1198","journal-title":"Diabetes Metab Res Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning JD","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, et al.. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004, 40:1387-95. 10.1002\/hep.20466","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi M","year":"2005","unstructured":"Hamaguchi M, Kojima T, Takeda N, et al.. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005, 143:722-8. 10.7326\/0003-4819-143-10-200511150-00009","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans RM","year":"2004","unstructured":"Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med. 2004, 10:355-61. 10.1038\/nm1025","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2004.07.005","article-title":"Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha","volume":"34","author":"Crabb DW","year":"2004","unstructured":"Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol. 2004, 34:35-8. 10.1016\/j.alcohol.2004.07.005","journal-title":"Alcohol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.02.011","article-title":"Pathogenesis of non-alcoholic steatohepatitis: human data","volume":"11","author":"Edmison J","year":"2007","unstructured":"Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis. 2007, 11:75-104, ix. 10.1016\/j.cld.2007.02.011","journal-title":"Clin Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning JD","year":"2004","unstructured":"Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004, 114:147-52. 10.1172\/JCI22422","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"123","author":"Bugianesi E","year":"2002","unstructured":"Bugianesi E, Leone N, Vanni E, et al.. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002, 123:134-40. 10.1053\/gast.2002.34168","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak M","year":"2015","unstructured":"Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2015, 62:720-33. 10.1016\/j.jhep.2014.10.039","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.045232","article-title":"Nonalcoholic fatty liver disease","volume":"172","author":"Adams LA","year":"2005","unstructured":"Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005, 172:899-905. 10.1503\/cmaj.045232","journal-title":"CMAJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.04058.x","article-title":"Fatty liver and the metabolic syndrome among Shanghai adults","volume":"20","author":"Fan JG","year":"2005","unstructured":"Fan JG, Zhu J, Li XJ, et al.. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol. 2005, 20:1825-32. 10.1111\/j.1440-1746.2005.04058.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1790-5","article-title":"Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease","volume":"41","author":"Eguchi Y","year":"2006","unstructured":"Eguchi Y, Eguchi T, Mizuta T, et al.. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006, 41:462-9. 10.1007\/s00535-006-1790-5","journal-title":"J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher G","year":"2005","unstructured":"Targher G, Bertolini L, Poli F, et al.. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005, 54:3541-6. 10.2337\/diabetes.54.12.3541","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study","volume":"25","author":"Brea A","year":"2005","unstructured":"Brea A, Mosquera D, Mart\u00edn E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol. 2005, 25:1045-50. 10.1161\/01.ATV.0000160613.57985.18","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1640-z","article-title":"Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes","volume":"48","author":"Reaven PD","year":"2005","unstructured":"Reaven PD, Sacks J. Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia. 2005, 48:379-85. 10.1007\/s00125-004-1640-z","journal-title":"Diabetologia"},{"key":"ref18","article-title":"A review of coronary artery disease research in Malaysia","volume":"71","author":"Ang CS","year":"2016","unstructured":"Ang CS, Chan KM. A review of coronary artery disease research in Malaysia. Med J Malaysia. 2016, 71:42-57.","journal-title":"Med J Malaysia"},{"key":"ref19","article-title":"Correlation between coronary calcium score, hepatic steatosis and metabolic syndrome","volume":"19","author":"Karina HM","year":"2013","unstructured":"Karina HM, Daniela PC, Julia AB, Claudio SF. Correlation between coronary calcium score, hepatic steatosis and metabolic syndrome. Rev Chilena Radiol. 2013, 19:64-8.","journal-title":"Rev Chilena Radiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.363","article-title":"Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging","volume":"71","author":"Motoyama S","year":"2007","unstructured":"Motoyama S, Kondo T, Anno H, et al.. Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J. 2007, 71:363-6. 10.1253\/circj.71.363","journal-title":"Circ J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000236507.76042.72","article-title":"Performance of subclinical arterial disease detection as a screening test for coronary heart disease","volume":"48","author":"Simon A","year":"2006","unstructured":"Simon A, Chironi G, Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension. 2006, 48:392-6. 10.1161\/01.HYP.0000236507.76042.72","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02188.x","article-title":"Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the diabetes heart study","volume":"103","author":"McKimmie RL","year":"2008","unstructured":"McKimmie RL, Daniel KR, Carr JJ, et al.. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the diabetes heart study. Am J Gastroenterol. 2008, 103:3029-35. 10.1111\/j.1572-0241.2008.02188.x","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00872-x","article-title":"Prediction of coronary events with electron beam computed tomography","volume":"36","author":"Arad Y","year":"2000","unstructured":"Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000, 36:1253-60. 10.1016\/s0735-1097(00)00872-x","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.2590","article-title":"Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT","volume":"194","author":"Boyce CJ","year":"2010","unstructured":"Boyce CJ, Pickhardt PJ, Kim DH, et al.. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol. 2010, 194:623-8. 10.2214\/AJR.09.2590","journal-title":"AJR Am J Roentgenol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2391050361","article-title":"Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment","volume":"239","author":"Park SH","year":"2006","unstructured":"Park SH, Kim PN, Kim KW, et al.. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006, 239:105-12. 10.1148\/radiol.2391050361","journal-title":"Radiology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.06.0992","article-title":"Comparison of CT methods for determining the fat content of the liver","volume":"188","author":"Kodama Y","year":"2007","unstructured":"Kodama Y, Ng CS, Wu TT, et al.. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007, 188:1307-12. 10.2214\/AJR.06.0992","journal-title":"AJR Am J Roentgenol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.019984","article-title":"Long term prognosis of fatty liver: risk of chronic liver disease and death","volume":"53","author":"Dam-Larsen S","year":"2004","unstructured":"Dam-Larsen S, Franzmann M, Andersen IB, et al.. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut. 2004, 53:750-5. 10.1136\/gut.2003.019984","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)01494-1","article-title":"Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study","volume":"87","author":"Djouss\u00e9 L","year":"2001","unstructured":"Djouss\u00e9 L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol. 2001, 87:1196-200; A4, 7. 10.1016\/s0002-9149(01)01494-1","journal-title":"Am J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams LA","year":"2005","unstructured":"Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005, 129:113-21. 10.1053\/j.gastro.2005.04.014","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark JM","year":"2003","unstructured":"Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003, 98:960-7. 10.1111\/j.1572-0241.2003.07486.x","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77009-association-of-hepatic-steatosis-with-coronary-artery-disease-by-studying-the-role-of-individual-and-demographic-risk-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:07Z","timestamp":1707508087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77009-association-of-hepatic-steatosis-with-coronary-artery-disease-by-studying-the-role-of-individual-and-demographic-risk-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.29444","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,22]]}}}